Multi-organ Transit Time Acquisition Using Contrast Ultrasound

Echocardiographic contrast will be administered to volunteers for the purpose of measuring transit time through various organs/vascular beds

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Healthy

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

VUMC

Nashville, Tennessee, 37232, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

at least 18 years old
able to give informed consent

Exclusion criteria

Known allergic reaction to Definity ultrasound contrast
Pregnancy/Nursing - as assessed/disclosed by the participant

Treatment and study plan

Definity Suspension for Injection

Drug

Administration of Definity

Primary outcomes

transit time

Time frame: during procedure

time it takes for contrast to traverse an organ

Sponsors and collaborators

Lead sponsor

Vanderbilt University Medical Center

Other

Registry information

Important dates

Study start: 2022
Primary completion: 2023
Study completion: 2025
First posted: Nov 26, 2021
Registry last updated: Jul 9, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed